Connection

Harm van Bakel to Receptor, Fibroblast Growth Factor, Type 2

This is a "connection" page, showing publications Harm van Bakel has written about Receptor, Fibroblast Growth Factor, Type 2.
  1. Midface and upper airway dysgenesis in FGFR2-related craniosynostosis involves multiple tissue-specific and cell cycle effects. Development. 2018 10 05; 145(19).
    View in: PubMed
    Score: 0.195
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.